Detailseite
Projekt Druckansicht

Modifiers of PINK1 function in Parkinson's disease

Antragsteller Dr. Norman Kock
Fachliche Zuordnung Klinische Neurologie; Neurochirurgie und Neuroradiologie
Förderung Förderung von 2006 bis 2009
Projektkennung Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 27685545
 
Erstellungsjahr 2009

Zusammenfassung der Projektergebnisse

Parkinson’s disease (PD) is associated with loss of dopaminergic cells and genetically linked to proteins that function in the management of cellular stress resulting from protein misfolding and oxidative damage. Mutations in the recently discovered PINK1 gene cause autosomal recessive PD. The main objective of this research study was to determine the molecular pathway of PINK1 and impact of mutated forms. We performed a mass spectroscopy analysis, using Stratagene’s Interplay Tandem Affinity Purification (TAP) system to identify novel interactors of PINK1. Several potential interactors have been identified, however confirmation studies are pending. Further, we could demonstrate that human skin fibroblasts containing mutated PINK1 display a mitochondrial dysfunction, with a p.V170G PINK1 mutation having an effect particularly on the respiratory chain.

Projektbezogene Publikationen (Auswahl)

  • Differential effects of PINK1 nonsense and missense mutations on mitochondrial function and morphology. AAN 2009. Supplement to Neurology Volume 72, Number 11, Supplement 3, Abstract P08.090
    Grünewald A, Gegg ME, Taanman JW, King RH, Klein C, Schapira AHV
 
 

Zusatzinformationen

Textvergrößerung und Kontrastanpassung